A C Hesseling
About
In The Last Decade
A C Hesseling
17 papers receiving 701 citations
Peers
Comparison fields: 5 of 57
- Infectious Diseases 671
- Epidemiology 569
- Surgery 243
- Molecular Biology 47
- Pediatrics, Perinatology and Child Health 42
Countries citing papers authored by A C Hesseling
This map shows the geographic impact of A C Hesseling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A C Hesseling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A C Hesseling more than expected).
Fields of papers citing papers by A C Hesseling
This network shows the impact of papers produced by A C Hesseling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A C Hesseling. The network helps show where A C Hesseling may publish in the future.
Co-authorship network of co-authors of A C Hesseling
This figure shows the co-authorship network connecting the top 25 collaborators of A C Hesseling. A scholar is included among the top collaborators of A C Hesseling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A C Hesseling. A C Hesseling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial. | 1 |
| 4 | 39 | |
| 5 | 34 | |
| 6 | 80 | |
| 7 | 44 | |
| 8 | 12 | |
| 9 | 33 | |
| 10 | 25 | |
| 11 | 28 | |
| 12 | Recording isoniazid preventive therapy delivery to children: operational challenges. | 34 |
| 13 | Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. | 32 |
| 14 | Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants: Submitted on behalf of the BCG Working Group, Child Lung Health Section, International Union Against Tuberculosis and Lung Disease, 38th Union World Conference on Lung Health, Cape Town, 8-12 November 2007. | 4 |
| 15 | An HIV-infected infant with Bacille Calmette-Guérin disease, recurrent and multidrug-resistant tuberculosis complicated by acute cor pulmonale and hepatitis while on antiretroviral therapy | 1 |
| 16 | Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. | 94 |
| 17 | Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. | 233 |
| 18 | HIV and childhood tuberculosis: the way forward. | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.